Biography
Alanna Bergman is a nurse scientist whose program of research includes social and structural barriers to tuberculosis and HIV care engagement. As a clinician providing care to people living with HIV and other infectious diseases, Alanna became particularly interested in stigma and its impact on an individual’s mental health, quality of life and ability to seek and complete treatment. Alanna uses qualitative, mixed-methods, and community-based research to explore and intervene upon social inequity.
Key Impacts
Substance use prevalence during TB treatment: A systematic review and meta-analysis in the African region
A systematic review of 19 African studies found a pooled prevalence of 11.3% for substance use among TB patients, with conflicting evidence on its impact on care engagement, highlighting the need for standardized definitions and data collection methods.
Source: Conference 2024
Acceptability of home-based TB prevention services by community health workers in the CHIP-TB trial
Overall, TPT delivered in a task-shared model was acceptable and CHWs overcame potential challenges to home-based care that supported TPT access and family-centered care.
Source: Conference 2024